case_images: PMC10515522_01
case_images: Treatment course. Sizing proportional to time on each treatment.
case_images: 10.1177_17588359231199877-fig1.jpg
case_images: PMC10515522_01_10.1177_17588359231199877-fig1.jpg
case_images: fig1-17588359231199877
case_images: After two cycles, restaging CT imaging showed progression of lung metastases and treatment was discontinued (Figure 1 and Table 2).
case_images: CT imaging of pulmonary metastases before immunotherapy (a) and after cycle 24 of pembrolizumab (b).
case_images: 10.1177_17588359231199877-fig2.jpg
case_images: PMC10515522_01_10.1177_17588359231199877-fig2.jpg
case_images: fig2-17588359231199877
case_images: After two cycles, restaging CT imaging showed progression of lung metastases and treatment was discontinued (Figure 1 and Table 2). She is planned for 2 years of immunotherapy (Figure 2).